Advanced Dermatology of the Midlands

Omaha, Nebraska 68144

0 studies enrolling now · 5 studies all time

What they study most

Alopecia Areata, Atopic Dermatitis, Chronic Spontaneous Urticaria, Hidradenitis Suppurativa, Psoriasis, Vitiligo

Studies at this site

• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) — Completed
• An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis — Stopped early
• A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC — Running, not enrolling
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) — Completed